Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Pharmacogenomics: An evolving clinical tool for precision medicine.

Hockings JK, Pasternak AL, Erwin AL, Mason NT, Eng C, Hicks JK.

Cleve Clin J Med. 2020 Feb;87(2):91-99. doi: 10.3949/ccjm.87a.19073. Review.

2.

Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene.

Hockings JK, Degner SC, Morgan SS, Kemp MQ, Romagnolo DF.

Breast Cancer Res. 2008;10(2):R29. doi: 10.1186/bcr1987. Epub 2008 Mar 31.

3.
4.

The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen.

Hockings JK, Thorne PA, Kemp MQ, Morgan SS, Selmin O, Romagnolo DF.

Cancer Res. 2006 Feb 15;66(4):2224-32.

5.

An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription.

Jeffy BD, Hockings JK, Kemp MQ, Morgan SS, Hager JA, Beliakoff J, Whitesell LJ, Bowden GT, Romagnolo DF.

Neoplasia. 2005 Sep;7(9):873-82.

Supplemental Content

Loading ...
Support Center